RELMADA THERAPEUTICS, INC. Accrued Liabilities
RELMADA THERAPEUTICS, INC. (RLMD) had Accrued Liabilities of $5.36 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities › Accrued Liabilities
us-gaap:AccruedLiabilitiesCurrentAndNoncurrent · last filed 2024-08-07
- 2024-06-30: Accrued Liabilities $5.36M.
- 2024-03-31: Accrued Liabilities $7.17M.
- 2023-12-31: Accrued Liabilities $8.69M.
- 2015-09-30: Accrued Liabilities $614.50K.
| Period end | Accrued Liabilities |
|---|---|
| 2024-06-30 | $5.36M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $7.17M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $8.69M 10-Q · filed 2024-08-07 |
| 2015-09-30 | $614.50K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $482.30K 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |